CAI
IDXX icon

Capital Advisors Inc’s Idexx Laboratories IDXX Stock Holding History

Capital Advisors Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
501
+13
+3% +$7.29K ﹤0.01% 325
2026
Q1 		$274K Sell
488
-9
-2% -$5.77K ﹤0.01% 305
2025
Q4 		$336K Buy
497
+5
+1% +$3.4K 0.01% 254
2025
Q3 		$314K Buy
492
+2
+0.4% +$1.21K 0.01% 249
2025
Q2 		$263K Buy
490
+5
+1% +$2.39K ﹤0.01% 278
2025
Q1 		$204K Sell
485
-11
-2% -$4.78K ﹤0.01% 299
2024
Q4 		$205K Buy
+496
New +$218K ﹤0.01% 294

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital Advisors Inc's IDXX Position: Q2 2026 in Review

Capital Advisors Inc increased its Idexx Laboratories (IDXX) stake by 2.7% in Q2 2026, buying an estimated $7.29K and bringing the position to 501 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #325.

Capital Advisors Inc first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $336K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Capital Advisors Inc held 501 shares of Idexx Laboratories worth $264K as of Q2 2026.
  • Capital Advisors Inc bought 13 Idexx Laboratories shares in Q2 2026, an estimated $7.29K.
  • Idexx Laboratories made up ﹤0.01% of Capital Advisors Inc's portfolio in Q2 2026, its #325 holding.
  • Capital Advisors Inc first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Capital Advisors Inc's Idexx Laboratories position peaked at $336K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.